If your child is taking medication for attention deficit hyperactivity disorder (ADHD), their doctor may soon offer a new option: fruit-flavored chewables.

The new drug, Adzenys, got FDA approval in January, and went on the market last week. But some psychiatrists are concerned that making amphetamines in a candy-like form will make people more likely to abuse them, and also contribute to what some see as a trend of overmedicating children.

Here & Now’s Robin Young talks with Meghana Keshavan, biotech correspondent at STAT.

• Read more via STAT

Guest

• Meghana Keshavan, biotech correspondent at STAT. She tweets @megkesh.

Copyright 2016 NPR. To see more, visit NPR.